Navigation Links
Tobacco Quit Line Expands Services for Pregnant Women Who Smoke
Date:5/8/2008

More than 8,700 babies born each year in Washington to smoking mothers

OLYMPIA, Wash., May 8 /PRNewswire-USNewswire/ -- Quitting smoking is one of the best things a woman can do to protect her own health and the health of her baby. In time for Mother's Day on May 11, the state Department of Health has added new services to its free Tobacco Quit Line to provide pregnant women with more help when they're ready to quit using tobacco.

The new tools include quit materials and extra follow-up calls specifically to help pregnant women increase their chances of quitting and remaining tobacco-free after the baby is born. Quit coaches have received additional training to better understand the challenges pregnant women face when trying to quit smoking. In Washington, more than 8,700 babies are born each year to women who smoke during their pregnancy.

"Quitting smoking is a Mother's Day gift that a pregnant woman can give to herself and her baby," said Secretary of Health Mary Selecky. "Babies with moms who smoke are more likely to die from Sudden Infant Death Syndrome and have health problems like ear infections and pneumonia. These new resources will make a real difference in the health of pregnant women and their babies."

The quit line (1-800-QUIT-NOW, and in Spanish, 1-877-2NO-FUME) provides free help to all pregnant women who smoke -- no insurance is required. Quit coaches help callers develop a quit plan and a strategy to avoid secondhand smoke before and after the baby is born. The quit line can supply free nicotine replacement medications when appropriate and approved by the woman's physician.

"It's vital that pregnant women get the support they need to quit for themselves and their babies," said Washington State Health Officer Dr. Maxine Hayes. "Health care providers can help ensure babies have a healthy start by asking patients about tobacco use and directing them to proven resources like the Tobacco Quit Line." '/>"/>

SOURCE Washington State Department of Health
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. AAPA Endorses 2008 Public Health Service Guidelines for Treating Tobacco Use and Dependence
2. A Statement from GlaxoSmithKline Consumer Healthcare on 2008 Update to the U.S. Public Health Service Guideline on Treating Tobacco Use and Dependence
3. Study Suggests Stronger Tobacco Control Policies in States With High Smoking Rates Would be Effective in Reducing Smoking and Saving Thousands of Lives
4. Oregon Supreme Court Rules in Favor of R.J. Reynolds Tobacco Company in Medical Monitoring Suit
5. New Report: Increasing Ohios Tobacco Tax Would Fund Economic Stimulus Plan and Preserve Highly-Successful Tobacco Prevention Program
6. American Legacy Foundation Steps Forward to Fight For, Safeguard Ohios Tobacco Settlement Dollars
7. Pennsylvania Attorney General Corbett, American Lung Association & Others Call for New MSA Funds to Be Used for Tobacco Prevention and Cessation
8. Shame on Governor Strickland, Ohio Legislators for Breaking Promise to Protect Kids from Tobacco
9. Statement from Lorillard Tobacco on FDA-Tobacco Regulation Legislation
10. R.J. Reynolds Tobacco Company Wins Appeal in Lights Case
11. Gov. Strickland, Legislative Leaders Break Promise to Protect Ohios Kids from Tobacco
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2008)...asize the Importance of Oral and Overall Health, ...ental insurer United,Concordia Dental is celebrati...ral Health America and the British Dental Health F... to overall health. Beginning May 18,this year,s ...rst time,making it the largest independent intern...
(Date:5/16/2008)...d at the American Society of Clinical Oncology mee...ment practice in about 25 percent of patients with...s to the way colorectal cancers will be staged. ,...e (NCI) SEER population-based statistic registries...ata, shows that outcomes of patients with positive...
(Date:5/16/2008)...sufferers gain benefit from calcitriol, an oral fo...- Taking activated vitamin D may cut the risk of d...dney disease by about one quarter, a new study sug...1,400 patients, those being treated with calcitrio...overall risk of death lowered by 26 percent when c...
(Date:5/16/2008)...t beneath the lining of the uterus (submucosal) ar...ter uterine artery embolization (UAE) but usually ... study. , The study included 49 patients with 1...e and after UAE. The study found that 39 of these ...ometrial cavity after UAE, said Sachit Verma, MD, ...
Breaking Medicine News(10 mins):Health News:United Concordia Dental Celebrates National Smile Month 2Health News:Vitamin D Use Linked to Lower Mortality in Kidney Patients 2
...harles Schumer was very upset and has sent a lette...ration, Dr. Andrew von Eschenbach. In his letter h...he problem.// The confusion started when it was r...d for the patients in case of tissue transplants. ...
...dic Hospital and Beach Resort, located close to Ko...packages for treatment of what is called new-age a...drome (CTS). //The unique health care service wou...eram chief Poly Mathew said Monday: "The hospital ...
... who found a birthmark in her child Matilda found ... internet search to understand the birthmark in he...said her not to panic after a little internet brow...e she contacted Great Ormond Street hospital, Lond...
...n study researchers have seen that people over 60 ... risk of dementia than teetotalers. The Medical Jo...s the lifestyle risk factors for developing dement... research of a sample of 2805 over-60s from Dubbo,...
Other Medicine News:
(Date:5/16/2008)...ting that TYKERB and trastuzumab together resulted...on-free survival (PFS), -- Combining TYKERB and t...f the HER2 receptor may create a more complete HER...ERB alone despite patients,previous treatment wit... LONDON and PHILADELPHIA, May 16 /PRNewswire-USNew...
(Date:5/16/2008)...er Novel Approach to Blood ...swire-FirstCall/ -- Pharmacopeia (Nasdaq:,PCOP), a...vel small,molecule therapeutics, announced today t...tor Antagonist (DARA), showed statistically signif...y in patients with mild to,moderate hypertension. ...
(Date:5/15/2008)... Patients with breast or,colorectal cancer, two of...er treatment advances with Avastin(R) (bevacizumab...a that is being presented at the 44th,American Soc... Chicago at,the end of May. Around 30,000 medical ...er event for cancer therapy worldwide., The Roche...
(Date:5/15/2008)...table Tolerability Profile, with Low I...AKE, N.J., May 15 /- The investigatio...9) demonstrated activity in a,heavily pretreated p...atic,breast cancer, according to results of a mult...uggests that eribulin mesylate has a manageable,to...
Breaking Medicine Technology:GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 2GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 3GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 4GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 5GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 6GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 7Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 2Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 3Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 4Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 5Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 6Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 7Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 8New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 2New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 3New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 4New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 5New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 6Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 2Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 3ACRIN Study Endorses Virtual Colonoscopy Validation for Colon CAD Software Maker Medicsight plc 440 1ACRIN Study Endorses Virtual Colonoscopy Validation for Colon CAD Software Maker Medicsight plc 440 2ACRIN Study Endorses Virtual Colonoscopy Validation for Colon CAD Software Maker Medicsight plc 440 3ACRIN Study Endorses Virtual Colonoscopy Validation for Colon CAD Software Maker Medicsight plc 440 4Naturally occurring apple compounds reduce risk of pancreatic cancer 668 1Naturally occurring apple compounds reduce risk of pancreatic cancer 668 2Type of ICU Influences Lung Injury Survival 2811 1Type of ICU Influences Lung Injury Survival 2811 2Study Finds Benefits With Drug Coated Stents 2808 1Study Finds Benefits With Drug Coated Stents 2808 2Study Finds Benefits With Drug Coated Stents 2808 3
...BUSINESS WIRE)--Jun 20, 2007 - Array BioPharma,Inc...ta on its MEK,inhibitor, ARRY-162, and its p38 inh...the Annual European Congress of Rheumatology,(EULA...ssociation,of Inflammation Societies, (IAIS) 8th W...rk., ARRY-162 / MEK Inhibitor Phase 1 Results , Ar...
...chusetts --- June,20, 2007 --- Millipore Corporati...ing its ReNcell neural stem cell lines. The,resea...at,University College London and ReNeuron Group pl...pore was announced in 2006. ,The data will be pres...ientist for Millipore’s Bioprocess Division,...
Other Medicine Technology:Array BioPharma Reports New Clinical Data on Its Anti-Inflammatory,Drugs 2Array BioPharma Reports New Clinical Data on Its Anti-Inflammatory,Drugs 3Array BioPharma Reports New Clinical Data on Its Anti-Inflammatory,Drugs 4Millipore Corporation Announces New ReNcell Data from Collaboration,with ReNeuron 2Millipore Corporation Announces New ReNcell Data from Collaboration,with ReNeuron 3Millipore Corporation Announces New ReNcell Data from Collaboration,with ReNeuron 4
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
Medicine Products: